MGMT methylation correlates with melphalan pelvic perfusion survival in stage III melanoma patients: a pilot study. - Wikidata - wikimedia - TriplyDB

MGMT methylation correlates with melphalan pelvic perfusion survival in stage III melanoma patients: a pilot study.

MGMT methylation correlates with melphalan pelvic perfusion survival in stage III melanoma patients: a pilot study.

http://www.wikidata.org/entity/Q30491635

about

Does Locoregional Chemotherapy Still Matter in the Treatment of Advanced Pelvic Melanoma?Aberrations and clinical significance of BRAF in malignant melanoma: A series of 60 cases in Chinese Uyghur.

P2860

Q47163375-577517B1-E1CB-4636-8840-64DBB6A396A0 Q54096030-78B33093-7E05-4672-8826-376FFD63A854

P2860

MGMT methylation correlates with melphalan pelvic perfusion survival in stage III melanoma patients: a pilot study.

http://www.wikidata.org/entity/Q30491635

description

2017 nî lūn-bûn

@nan

2017 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

MGMT methylation correlates wi ...... anoma patients: a pilot study.

@ast

MGMT methylation correlates wi ...... anoma patients: a pilot study.

@en

type

label

MGMT methylation correlates wi ...... anoma patients: a pilot study.

@ast

MGMT methylation correlates wi ...... anoma patients: a pilot study.

@en

prefLabel

MGMT methylation correlates wi ...... anoma patients: a pilot study.

@ast

MGMT methylation correlates wi ...... anoma patients: a pilot study.

@en

P1433

Q30491635-7DD3A31E-6722-4056-BDDA-7D06E787C8B1

P1476

Q30491635-D3928BAB-65F2-4F08-9F85-4929A9D02BC4

P2093

Q30491635-057E0D85-2BF0-484D-ADEC-7526307F931A

Q30491635-2FCEEFE2-FB1D-447F-B274-98967C542290

Q30491635-6F898BAA-4AD0-4F2D-B45A-3B1DD07FCBBB

Q30491635-A6DC49B3-5472-460D-8603-E26F5C777B09

Q30491635-CFF8D644-6F48-43D9-BD04-58FE720B1206

Q30491635-D0C69F18-168B-42C6-AD2E-62181BDF54B5

P2860

Q30491635-15B0396F-AB3E-4FA7-906A-697C2AB76F7E

Q30491635-38A4E542-61E8-402B-8D9C-53405370BB2D

Q30491635-3E321553-6F45-4958-B04A-C251D54353A2

Q30491635-42C70628-666E-4E70-92D7-D57CD8328B92

Q30491635-430A7AB9-5A1F-4162-9F92-50BA684F1F73

Q30491635-43BBF3CC-C6BB-40E2-913A-A547474CC67C

Q30491635-5D74FA06-1BCF-4FB6-89AC-E2A847FFE78C

Q30491635-60FA5CD4-AD19-41AE-882B-3A021CE55406

Q30491635-61F2D83E-5BF4-4ACC-877E-21F20F8FF297

Q30491635-694F27B5-90C0-4E76-BA76-8D918B7EBDAC

P304

Q30491635-F096DDE4-C1DD-42CE-98C7-B93D235865C0

P31

Q30491635-A3805E0C-90DA-4282-89F5-51A8426961A9

P356

Q30491635-20157C9B-7272-488A-B648-1FE0E1E5168D

P407

Q30491635-7BC7515A-568D-4410-BCA5-C43D9F87E240

P433

Q30491635-60D9D03F-E749-4F2C-BFDB-F81AE3960D6A

P478

Q30491635-36DCA848-4F89-4C7E-B7B7-C81B06153F4A

P50

Q30491635-0B03788D-4D8D-4677-AE04-E59D1A30B604

Q30491635-55F8EFEB-342A-44FF-A051-FF6C51107AFA

Q30491635-B5D7D0C1-8751-47F5-B808-849E08A2B129

Q30491635-F698F7E1-A50A-4981-BBB2-8D206198D5FB

P577

Q30491635-B4F812B4-77E2-400D-8E23-B19773CBE4A8

P698

Q30491635-87413D55-B751-4304-A8D8-516712DD2DB2

P932

Q30491635-49F332E4-F354-47F6-9F8D-F9F43CC685FE

P356

CMR.0000000000000367

P1433

Melanoma Research

P1476

MGMT methylation correlates wi ...... anoma patients: a pilot study.

@en

P2093

Alessandro Chiominto

http://www.w3.org/2001/XMLSchema#string

Cristina Pellegrini

http://www.w3.org/2001/XMLSchema#string

Giammaria Fiorentini

http://www.w3.org/2001/XMLSchema#string

Giancarlo Palumbo

http://www.w3.org/2001/XMLSchema#string

Giovanni De Manzoni

http://www.w3.org/2001/XMLSchema#string

Marcello Deraco

http://www.w3.org/2001/XMLSchema#string

P2860

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents.

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Final version of 2009 AJCC melanoma staging and classification

The state of melanoma: challenges and opportunities

MGMT gene promoter methylation correlates with tolerance of temozolomide treatment in melanoma but not with clinical outcome.

O6-methylguanine-DNA methyltransferase in the defense against N-nitroso compounds and colorectal cancer.

Usefulness of MS-MLPA for detection of MGMT promoter methylation in the evaluation of pseudoprogression in glioblastoma patients.

A multicenter phase I dose escalation trial to evaluate safety and tolerability of intra-arterial temozolomide for patients with advanced extremity melanoma using normothermic isolated limb infusion.

O6-methylguanine DNA methyltransferase as a promising target for the treatment of temozolomide-resistant gliomas

Repairing of N-mustard derivative BO-1055 induced DNA damage requires NER, HR, and MGMT-dependent DNA repair mechanisms

P304

439-447

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/CMR.0000000000000367

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

27

http://www.w3.org/2001/XMLSchema#string

P50

Stefano Guadagni

Francesco Masedu

P577

2017-05-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28486243

http://www.w3.org/2001/XMLSchema#string

P932

5592983

http://www.w3.org/2001/XMLSchema#string